94 related articles for article (PubMed ID: 27977601)
1. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis.
Xiao Q; Fu B; Chen P; Liu ZZ; Wang W; Ye Q
Medicine (Baltimore); 2016 Dec; 95(50):e5609. PubMed ID: 27977601
[TBL] [Abstract][Full Text] [Related]
2. Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
Zeng Z; Liao X; Huang K; Han C; Qin W; Su H; Ye X; Yang C; Zhou X; Wei Y; Mo S; Liu J; Lan C; Huang X; Huang Z; Peng K; Gao Q; Peng T; Zhu G
World J Surg Oncol; 2023 Oct; 21(1):322. PubMed ID: 37833735
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis.
Tavakolpour S; Sali S
Hepat Mon; 2016 Apr; 16(4):e33537. PubMed ID: 27257425
[TBL] [Abstract][Full Text] [Related]
4. Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV-related hepatocellular carcinoma risk: A system review and meta-analysis.
Dong X; Zou M; Li C; Luo H; Zhu S; Gong Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38634192
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis.
Yin X; Kan F
Cancer Epidemiol; 2023 Dec; 87():102457. PubMed ID: 37797398
[TBL] [Abstract][Full Text] [Related]
6. TNF-α -863 polymorphisms and the risk of hepatocellular carcinoma.
Yang Y; Qiu XQ; Yu HP; Zeng XY; Bei CH
Exp Ther Med; 2012 Mar; 3(3):513-518. PubMed ID: 22969921
[TBL] [Abstract][Full Text] [Related]
7. Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study.
Tanouti IA; Fellah H; El Fihry R; Zerrad C; Abounouh K; Tahiri M; Belkouchi A; Badre W; Pineau P; Benjelloun S; Ezzikouri S
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3689-3696. PubMed ID: 38019226
[TBL] [Abstract][Full Text] [Related]
8. THE PREVALENCE OF C3953T IL1Β GENE AND G308A TNFΑ GENE POLYMORPHIC VARIANTS IN THE PATIENTS WITH DIFFERENT TYPES OF ENCEPHALOPATHIES.
Duve K
Georgian Med News; 2023; (340-341):264-269. PubMed ID: 37805909
[TBL] [Abstract][Full Text] [Related]
9.
Wang Y; Gao F; Lu J
Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-11. PubMed ID: 38728583
[TBL] [Abstract][Full Text] [Related]
10. Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival.
Jiang B; Qiu M; Qin L; Tang J; Zhan S; Lin Q; Wei J; Liu Y; Zhou Z; Liang X; Cao J; Lian J; Mai Y; Jiang Y; Yu H
Front Oncol; 2023; 13():1252158. PubMed ID: 38260847
[TBL] [Abstract][Full Text] [Related]
11. System Biology Investigation Revealed Lipopolysaccharide and Alcohol-Induced Hepatocellular Carcinoma Resembled Hepatitis B Virus Immunobiology and Pathogenesis.
Patil VS; Harish DR; Sampat GH; Roy S; Jalalpure SS; Khanal P; Gujarathi SS; Hegde HV
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446321
[TBL] [Abstract][Full Text] [Related]
12. Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review.
Kitsou K; Iliopoulou M; Spoulou V; Lagiou P; Magiorkinis G
Front Oncol; 2021; 11():687631. PubMed ID: 34778024
[TBL] [Abstract][Full Text] [Related]
13. Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto ; Handajani R
BMC Cancer; 2020 Nov; 20(1):1134. PubMed ID: 33228594
[TBL] [Abstract][Full Text] [Related]
14. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
Kumar A; Acharya SK; Singh SP; Arora A; Dhiman RK; Aggarwal R; Anand AC; Bhangui P; Chawla YK; Datta Gupta S; Dixit VK; Duseja A; Kalra N; Kar P; Kulkarni SS; Kumar R; Kumar M; Madhavan R; Mohan Prasad VG; Mukund A; Nagral A; Panda D; Paul SB; Rao PN; Rela M; Sahu MK; Saraswat VA; Shah SR; Shalimar ; Sharma P; Taneja S; Wadhawan M;
J Clin Exp Hepatol; 2020; 10(1):43-80. PubMed ID: 32025166
[TBL] [Abstract][Full Text] [Related]
15. Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients.
Wungu CDK; Amin M; Ruslan SEN; Purwono PB; Kholili U; Maimunah U; Setiawan PB; Lusida MI; Soetjipto S; Handajani R
Biomed Rep; 2019 Oct; 11(4):145-153. PubMed ID: 31565220
[TBL] [Abstract][Full Text] [Related]
16. TNF-α polymorphisms affect persistence and progression of HBV infection.
Woziwodzka A; Rybicka M; Sznarkowska A; Romanowski T; Dręczewski M; Stalke P; Bielawski KP
Mol Genet Genomic Med; 2019 Oct; 7(10):e00935. PubMed ID: 31441603
[TBL] [Abstract][Full Text] [Related]
17. TNF-α G-308A genetic variants, serum CRP-hs concentration and DNA damage in obese women.
Włodarczyk M; Ciebiera M; Nowicka G
Mol Biol Rep; 2020 Feb; 47(2):855-866. PubMed ID: 30900134
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the 3'-UTR of SCD5 gene are associated with hepatocellular carcinoma in Korean population.
Yu GI; Mun KH; Yang SH; Shin DH; Hwang JS
Mol Biol Rep; 2018 Dec; 45(6):1705-1714. PubMed ID: 30168096
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor: The key to hepatitis B viral clearance.
Chyuan IT; Hsu PN
Cell Mol Immunol; 2018 Aug; 15(8):731-733. PubMed ID: 29375133
[No Abstract] [Full Text] [Related]
20. Association of
Zhang Y; Wang S; Wen X; Zhang S; Yang Y
Oncotarget; 2017 Oct; 8(49):86011-86019. PubMed ID: 29156773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
